[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2011 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
01-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- -8.82%
YoY- 23.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 1,806,964 1,786,980 1,520,981 1,537,593 1,563,526 1,541,312 1,378,348 19.80%
PBT 141,146 171,820 73,186 75,757 82,344 87,168 45,462 112.96%
Tax -50,870 -55,576 -20,401 -21,620 -23,056 -24,772 -15,152 124.37%
NP 90,276 116,244 52,785 54,137 59,288 62,396 30,310 107.14%
-
NP to SH 88,796 114,740 52,157 53,620 58,808 61,936 30,384 104.54%
-
Tax Rate 36.04% 32.35% 27.88% 28.54% 28.00% 28.42% 33.33% -
Total Cost 1,716,688 1,670,736 1,468,196 1,483,456 1,504,238 1,478,916 1,348,038 17.50%
-
Net Worth 481,282 474,161 514,273 464,307 451,381 437,661 421,524 9.24%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 35,301 35,297 35,304 - - - 10,698 121.80%
Div Payout % 39.76% 30.76% 67.69% - - - 35.21% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 481,282 474,161 514,273 464,307 451,381 437,661 421,524 9.24%
NOSH 117,672 117,657 117,682 106,983 106,962 107,007 106,985 6.55%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 5.00% 6.51% 3.47% 3.52% 3.79% 4.05% 2.20% -
ROE 18.45% 24.20% 10.14% 11.55% 13.03% 14.15% 7.21% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 1,535.58 1,518.79 1,292.44 1,437.23 1,461.75 1,440.38 1,288.35 12.42%
EPS 75.46 97.52 44.32 50.12 54.98 57.88 28.40 91.95%
DPS 30.00 30.00 30.00 0.00 0.00 0.00 10.00 108.14%
NAPS 4.09 4.03 4.37 4.34 4.22 4.09 3.94 2.52%
Adjusted Per Share Value based on latest NOSH - 106,933
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 125.37 123.99 105.53 106.68 108.48 106.94 95.64 19.79%
EPS 6.16 7.96 3.62 3.72 4.08 4.30 2.11 104.40%
DPS 2.45 2.45 2.45 0.00 0.00 0.00 0.74 122.30%
NAPS 0.3339 0.329 0.3568 0.3222 0.3132 0.3037 0.2925 9.23%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 10.18 5.90 5.36 5.90 5.90 5.73 5.31 -
P/RPS 0.66 0.39 0.41 0.41 0.40 0.40 0.41 37.39%
P/EPS 13.49 6.05 12.09 11.77 10.73 9.90 18.70 -19.58%
EY 7.41 16.53 8.27 8.49 9.32 10.10 5.35 24.27%
DY 2.95 5.08 5.60 0.00 0.00 0.00 1.88 35.07%
P/NAPS 2.49 1.46 1.23 1.36 1.40 1.40 1.35 50.45%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 -
Price 8.83 5.90 5.90 5.90 5.90 5.05 5.35 -
P/RPS 0.58 0.39 0.46 0.41 0.40 0.35 0.42 24.03%
P/EPS 11.70 6.05 13.31 11.77 10.73 8.72 18.84 -27.23%
EY 8.55 16.53 7.51 8.49 9.32 11.46 5.31 37.41%
DY 3.40 5.08 5.08 0.00 0.00 0.00 1.87 49.02%
P/NAPS 2.16 1.46 1.35 1.36 1.40 1.23 1.36 36.16%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment